ScreenerHero
HEMHemostemix Inc.
TSXV · CA · Healthcare · Biotechnology · hemostemix.com
0.0800CAD+23.08%Mkt Cap: 12.32M $P/E: —

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap12.32M $
Enterprise Value13.92M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.43M $
Revenue/Share—
Last Price0.0800 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.57
PEG—
EV/EBITDA-3.92
EV/Revenue—
P/S—
P/B-2.86
EPS (TTM)-0.02
EPS (Forward)-0.14
52W Range
0.040042% of range0.1350
52W High0.1350 CAD
52W Low0.0400 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE94.80%
ROA-556.61%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.30M $
CapEx (TTM)—
FCF Margin—
FCF Yield-25.83%
Net Debt2.40M $
Net Debt/EBITDA-0.68
Balance Sheet
Debt/Equity-0.72
Current Ratio0.24
Quick Ratio0.21
Book Value/Sh-0.0280 CAD
Cash/Share0.0020 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 30, 2020
Splits
Last Split1:20
Split DateDec 30, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.211.44M
Float154.76M
Insiders17.15%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Out.0.00%
Shares Short3.62K
Short (prev mo.)16.59K
Technical
SMA 500.0609 (+31.4%)
SMA 2000.0735 (+8.9%)
Beta0.61
S&P 52W Chg18.16%
Avg Vol (30d)30.95K
Avg Vol (10d)26.29K
Technical Indicators
RSI (14)65.4
MACD0.0033
MACD Signal0.0023
MACD Hist.+0.0011
BB Upper0.0747 CAD
BB Middle0.0648 CAD
BB Lower0.0548 CAD
BB Width30.85%
ATR (14)0.0052 CAD
Vol Ratio (20d)0.29x